Search bioRxiv⌕ Search

Biology subjects

Reese, M.

Publications and source records attributed to Reese, M..

2 recordsLinked to original sources

The effects of dietary iron supplementation on bacterial infections in Manduca sexta larval hemolymph

Iron is an essential nutrient for all types of organisms, including insects and the microbes that infect them. We predicted that insects fed an iron-supplemented diet would accumulate more iron in their hemolymph, and, because infectious microbes acquire iron from their hosts, that this extra iron would increase the severity of bacterial infections. To test this hypothesis, we studied the effects of dietary iron supplementation on infection outcomes in Manduca sexta (tobacco hornworm). Larvae were fed an artificial diet, with or without antibiotics, or the same diets supplemented with 10 mM iron. Control and iron-treated larvae were inoculated with non-pathogenic Escherichia coli or the entomopathogenic Enterococcus faecalis, and bacterial load and larval survival were measured. We found that dietary iron supplementation increased the iron content of hemolymph by approximately 20 fold; however, contrary to our prediction, this increase in iron did not result in an increase in the bacterial load of either E. coli or E. faecalis. The effect of iron supplementation on survival was more complicated. As expected, for larvae inoculated with nonpathogenic E. coli, iron supplementation had no effect. For larvae inoculated with E. faecalis, the effect of iron supplementation depended on whether antibiotics were present in the diet. Without antibiotics, iron supplementation prolonged larval survival; with antibiotics, iron supplementation decreased larval survival. The results of this study do not support the hypothesis that dietary iron supplementation increases infection severity in M. sexta. Instead, the results support the viewpoint that the relationship between dietary iron and infection outcome is complex.

physiology↗

Establishment and Characterization of a CCND1-Rearranged Non-Mantle Cell Lymphoma Cell Line and Patient-Derived Xenograft Model

The pathobiology of aggressive B-cell lymphomas with CCND1 rearrangements, distinct from Mantle Cell Lymphoma (MCL), presents a significant clinical challenge. These lymphomas are often difficult to diagnose and demonstrate resistance to standard immunochemotherapy, underscoring the urgent need for a deeper understanding of their underlying biology to develop more effective treatments. A major impediment to progress has been the lack of robust preclinical models that accurately reflect the complex genomics and clinical behavior of this disease. Here we directly address this critical gap by reporting the establishment and in-depth characterization of the first patient-derived cell line and a corresponding systemic patient-derived xenograft (PDX) model of a CCND1-rearranged, non-MCL lymphoma with a rapidly fatal clinical course. Through a comprehensive multi-omics approach, we demonstrate that these novel in vitro and in vivo models faithfully recapitulate the primary tumors unique immunophenotype, its intricate genetic and transcriptional landscape, and its intrinsic resistance to conventional therapeutic agents.

cancer biology↗